BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23167979)

  • 1. Intraoperative high-dose-rate brachytherapy using dose painting technique: evaluation of safety and preliminary clinical outcomes.
    Morikawa LK; Zelefsky MJ; Cohen GN; Zaider M; Chiu J; Mathur N; Worman MF; Goodman KA
    Brachytherapy; 2013; 12(1):1-7. PubMed ID: 23167979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer.
    Tan J; Heriot AG; Mackay J; Van Dyk S; Bressel MA; Fox CD; Hui AC; Lynch AC; Leong T; Ngan SY
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):617-25. PubMed ID: 24119279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate intraoperative radiation therapy for colorectal cancer.
    Harrison LB; Enker WE; Anderson LL
    Oncology (Williston Park); 1995 Aug; 9(8):737-41; discussion 742-8 passim. PubMed ID: 7577374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer.
    Harrison LB; Minsky BD; Enker WE; Mychalczak B; Guillem J; Paty PB; Anderson L; White C; Cohen AM
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):325-30. PubMed ID: 9788411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
    Perry DJ; Chan K; Wolden S; Zelefsky MJ; Chiu J; Cohen G; Zaider M; Kraus D; Shah J; Lee N
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1140-6. PubMed ID: 19560882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative Electron Beam Radiation Therapy (IOERT) Versus High-Dose-Rate Intraoperative Brachytherapy (HDR-IORT) in Patients With an R1 Resection for Locally Advanced or Locally Recurrent Rectal Cancer.
    Voogt ELK; van Rees JM; Hagemans JAW; Rothbarth J; Nieuwenhuijzen GAP; Cnossen JS; Peulen HMU; Dries WJF; Nuyttens J; Kolkman-Deurloo IK; Verhoef C; Rutten HJT; Burger JWA
    Int J Radiat Oncol Biol Phys; 2021 Jul; 110(4):1032-1043. PubMed ID: 33567303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience.
    Hyngstrom JR; Tzeng CW; Beddar S; Das P; Krishnan S; Delclos ME; Crane CH; Chang GJ; You YN; Feig BW; Skibber JM; Rodriguez-Bigas MA
    J Surg Oncol; 2014 Jun; 109(7):652-8. PubMed ID: 24510523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20-year experience with intraoperative high-dose-rate brachytherapy for pediatric sarcoma: outcomes, toxicity, and practice recommendations.
    Folkert MR; Tong WY; LaQuaglia MP; Wexler LH; Chou AJ; Magnan H; Zelefsky MJ; Wolden SL
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):362-8. PubMed ID: 25304795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.
    Narayana A; Cohen GN; Zaider M; Chan K; Lee N; Wong RJ; Boyle J; Shaha A; Kraus D; Shah J; Zelefsky MJ
    Brachytherapy; 2007; 6(2):157-63. PubMed ID: 17434110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
    Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
    Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison of (192)Ir high-dose-rate brachytherapy vs. 50 kV x-rays as techniques for breast intraoperative radiation therapy: conceptual development of image-guided intraoperative brachytherapy using a multilumen balloon applicator and in-room CT imaging.
    Jones R; Libby B; Showalter SL; Brenin DR; Wilson DD; Schroen A; Morris M; Reardon KA; Morrison J; Showalter TN
    Brachytherapy; 2014; 13(5):502-7. PubMed ID: 24933339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High- and low-dose-rate intraoperative radiotherapy for thoracic malignancies resected with close or positive margins.
    Fleming C; Rimner A; Cohen GN; Woo KM; Zhang Z; Rosenzweig KE; Alektiar KM; Zelefsky MJ; Bains MS; Wu AJ
    Brachytherapy; 2016; 15(2):208-15. PubMed ID: 26825857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Form of Breast Intraoperative Radiation Therapy With CT-Guided High-Dose-Rate Brachytherapy: Results of a Prospective Phase 1 Clinical Trial.
    Showalter SL; Petroni G; Trifiletti DM; Libby B; Schroen AT; Brenin DR; Dalal P; Smolkin M; Reardon KA; Showalter TN
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):46-54. PubMed ID: 27511846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiotherapy for parotid cancer: a single-institution experience.
    Zeidan YH; Shiue K; Weed D; Johnstone PA; Terry C; Freeman S; Krowiak E; Borrowdale R; Huntley T; Yeh A
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1831-6. PubMed ID: 21514074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.
    Terezakis S; Morikawa L; Wu A; Zhang Z; Shi W; Weiser MR; Paty PB; Guillem J; Temple L; Nash GM; Zelefsky MJ; Goodman KA
    Ann Surg Oncol; 2015 Jul; 22(7):2168-78. PubMed ID: 25631062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.